Hongwei Xia

2.8k total citations · 2 hit papers
73 papers, 2.0k citations indexed

About

Hongwei Xia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Hongwei Xia has authored 73 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 22 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Hongwei Xia's work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (10 papers) and Hippo pathway signaling and YAP/TAZ (9 papers). Hongwei Xia is often cited by papers focused on Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (10 papers) and Hippo pathway signaling and YAP/TAZ (9 papers). Hongwei Xia collaborates with scholars based in China, United States and Switzerland. Hongwei Xia's co-authors include Qiulin Tang, Feng Bi, Feng Bi, Huanji Xu, Sheng Zhou, Gongmin Zhu, Lijiao Pei, Qiyong Gong, Weibing Leng and Guoqing Wei and has published in prestigious journals such as The Lancet, PLoS ONE and Scientific Reports.

In The Last Decade

Hongwei Xia

66 papers receiving 2.0k citations

Hit Papers

Role of oncogenic KRAS in the prognosis, diagnosis and tr... 2020 2026 2022 2024 2021 2020 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hongwei Xia China 25 1.1k 828 427 267 241 73 2.0k
Mohammed Soutto United States 29 1.1k 1.0× 497 0.6× 485 1.1× 321 1.2× 411 1.7× 61 2.0k
Shu‐Heng Jiang China 26 1.2k 1.1× 792 1.0× 439 1.0× 287 1.1× 115 0.5× 75 2.1k
Shan Yu China 32 1.5k 1.3× 749 0.9× 401 0.9× 350 1.3× 176 0.7× 89 2.4k
Maode Wang China 22 1.2k 1.1× 768 0.9× 479 1.1× 189 0.7× 89 0.4× 71 1.9k
Yuyan Zhu China 23 937 0.8× 525 0.6× 212 0.5× 242 0.9× 176 0.7× 104 1.7k
Rossano Lattanzio Italy 29 1.3k 1.1× 436 0.5× 959 2.2× 290 1.1× 229 1.0× 83 2.7k
Eun Sung Park United States 25 1.5k 1.3× 722 0.9× 638 1.5× 525 2.0× 317 1.3× 45 2.6k
George Kulik United States 22 1.7k 1.5× 442 0.5× 568 1.3× 321 1.2× 114 0.5× 38 2.7k

Countries citing papers authored by Hongwei Xia

Since Specialization
Citations

This map shows the geographic impact of Hongwei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongwei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongwei Xia more than expected).

Fields of papers citing papers by Hongwei Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongwei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongwei Xia. The network helps show where Hongwei Xia may publish in the future.

Co-authorship network of co-authors of Hongwei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Hongwei Xia. A scholar is included among the top collaborators of Hongwei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongwei Xia. Hongwei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Xia, Hongwei, Pengbo Zhang, Qi Zhang, et al.. (2025). Spatio-temporal dynamics and drivers of cropland ecosystem services value during the past two decades in Yangtze river economic belt, China. Frontiers in Public Health. 13. 1622093–1622093.
3.
Zhang, Jincheng, et al.. (2024). Targeting the GDF15 Signalling for Obesity Treatment: Recent Advances and Emerging Challenges. Journal of Cellular and Molecular Medicine. 28(24). e70251–e70251.
5.
Ding, Zhijie, et al.. (2024). NeuroPpred-SHE: An interpretable neuropeptides prediction model based on selected features from hand-crafted features and embeddings of T5 model. Computers in Biology and Medicine. 181. 109048–109048. 1 indexed citations
6.
Xia, Hongwei, et al.. (2024). SGTCDA: Prediction of circRNA-drug sensitivity associations with interpretable graph transformers and effective assessment. BMC Genomics. 25(1). 1113–1113. 2 indexed citations
7.
Tang, Qiulin, Huanji Xu, Hongwei Xia, et al.. (2024). Endogenous Coriobacteriaceae enriched by a high-fat diet promotes colorectal tumorigenesis through the CPT1A-ERK axis. npj Biofilms and Microbiomes. 10(1). 5–5. 21 indexed citations
8.
Qin, Xuan, et al.. (2023). Development and validation of a nomogram for predicting overall survival in patients with stage III-N2 lung adenocarcinoma based on the SEER database. Translational Cancer Research. 12(10). 2742–2753. 2 indexed citations
9.
Zhu, Gongmin, Lijiao Pei, Hongwei Xia, Qiulin Tang, & Feng Bi. (2021). Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Molecular Cancer. 20(1). 143–143. 265 indexed citations breakdown →
10.
Yu, Long, Yonghua Jiang, Jingjing Zeng, et al.. (2020). The expression and biological function of chemokine CXCL12 and receptor CXCR4/CXCR7 in placenta accreta spectrum disorders. Journal of Cellular and Molecular Medicine. 24(5). 3167–3182. 14 indexed citations
11.
Ma, Ji, Zhenhai Fan, Qiulin Tang, et al.. (2020). Aspirin attenuates YAP and β-catenin expression by promoting β-TrCP to overcome docetaxel and vinorelbine resistance in triple-negative breast cancer. Cell Death and Disease. 11(7). 530–530. 14 indexed citations
12.
Zhou, Sheng, Huanji Xu, Qiulin Tang, Hongwei Xia, & Feng Bi. (2019). Dipyridamole Enhances the Cytotoxicities of Trametinib against Colon Cancer Cells through Combined Targeting of HMGCS1 and MEK Pathway. Molecular Cancer Therapeutics. 19(1). 135–146. 35 indexed citations
13.
Hou, Wanting, Hongwei Xia, Sheng Zhou, et al.. (2019). The MEK inhibitors enhance the efficacy of sorafenib against hepatocellular carcinoma cells through reducing p-ERK rebound. Translational Cancer Research. 8(4). 1224–1232. 1 indexed citations
14.
Chen, Chang, Jinwen Zhang, Hongwei Xia, et al.. (2018). Epidemiology of preterm birth in China in 2015 and 2016: a nationwide survey. The Lancet. 392. S73–S73. 11 indexed citations
15.
Zhou, Sheng, Hongwei Xia, Huanji Xu, et al.. (2018). ERRα suppression enhances the cytotoxicity of the MEK inhibitor trametinib against colon cancer cells. Journal of Experimental & Clinical Cancer Research. 37(1). 218–218. 26 indexed citations
16.
Xia, Hongwei, Qiulin Tang, Huanji Xu, et al.. (2017). Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation. Scientific Reports. 7(1). 40802–40802. 85 indexed citations
17.
Wu, Yangping, Xi Chen, Xiaojun Ge, et al.. (2015). Isoliquiritigenin prevents the progression of psoriasis-like symptoms by inhibiting NF-κB and proinflammatory cytokines. Journal of Molecular Medicine. 94(2). 195–206. 39 indexed citations
18.
Yuan, Dandan, Liang Chen, Mingxing Li, et al.. (2014). Isolation and characterization of circulating tumor cells from human gastric cancer patients. Journal of Cancer Research and Clinical Oncology. 141(4). 647–660. 24 indexed citations
19.
Pang, Xiaohui, et al.. (2013). Radiotherapy for gastric cancer: a systematic review and meta-analysis. Tumor Biology. 35(1). 387–396. 20 indexed citations
20.
Yan, Bo, Yi Li, Jian Pan, Hongwei Xia, & Longjiang Li. (2010). Primary oral leiomyosarcoma: a retrospective clinical analysis of 20 cases. Oral Diseases. 16(2). 198–203. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026